Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- Disney Furloughs 100,000 Workers While Top Executives Will Still Get Big Bonuses also categorized in BoardNews
- Vivendi Employees Back Bollore Against Activist Challenge also written by Reuters
- Germany's Corporate Governance Problem also categorized in BoardNews
- Lululemon Has A New CEO also written by Reuters
- These Are The People Who Will Be Soaked In Cash After Twitter's IPO also written by Reuters
- Exclusive: Proxy firm Egan-Jones Withdraws Recommendation on Tempur Sealy also written by Reuters
- McDonald’s Board Members Sued Over ‘Lavish’ $56 Million Severance for Fired CEO Easterbrook also published in Chicago Tribune
- Two Shareholders Sue American Apparel Over CEO's Ouster also written by Reuters
- Why Illinois Shouldn't Mandate Quotas for Company Boards also published in Chicago Tribune
- A Changed and Changing Executive Compensation Environment also mentions Disclosures on Compensation
Login to comment.